Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients
- PMID: 23312542
- PMCID: PMC3593808
- DOI: 10.1016/j.oooo.2012.10.012
Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients
Abstract
Objective: We monitored the epidemiology and microbiology of oral yeast colonization in patients undergoing hemopoietic progenitor cell transplantation (HPCT) to examine associations between yeast colonization and oral mucositis.
Study design: One hundred twenty-one consecutive HPCT patients were sampled for oral yeasts prior to fluconazole (FLC) prophylaxis, at transplantation, and weekly until discharge. Clinical oral mucositis screenings were performed triweekly.
Results: Yeast colonization was evident at 216 of 510 total visits. Candida albicans and Candida glabrata were the predominant organisms. Eight patients showed elevated minimal inhibitory concentrations to FLC. One patient developed fungal septicemia. Patients with oral mucositis assessment scale scores <20 had higher colonization rates than those with higher scores.
Conclusions: FLC is effective in controlling a variety of oral yeasts in HPCT recipients. FLC-resistant yeasts do emerge and can be the source of fungal sepsis. A positive association was not shown between yeast colonization and the presence or severity of oral mucositis.
Copyright © 2013 Elsevier Inc. All rights reserved.
Conflict of interest statement
TFP: Research Support/Consultant: Astellas Pharma US, Merck & Co., Viamet Pharmaceuticals, Inc., Toyama Chemical Company, and Pfizer Inc. SWR: Research Support: Pfizer Inc., Merck & Co., Astellas Pharma US Inc. NPW: Research Support/Consultant: Astellas Pharma US, Merck & Co., CyDex, Viamet Pharmaceuticals, Inc., Toyama Chemical Company, and Pfizer Inc. SDW, WRK, JJT, COF: None to declare.
Figures
References
-
- Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–26. - PubMed
-
- Epstein JB, Raber-Durlacher JE, Wilkins A, Chavarria MG, Myint H. Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:301–12. - PubMed
-
- Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091–100. - PubMed
-
- Marr KA, Bow E, Chiller T, Maschmeyer G, Ribaud P, Segal B, et al. Fungal infection prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009;44:483–7. - PubMed
-
- Wirk B, Wingard JR. Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients. Mycopathologia. 2009;168:299–311. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources